V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003115 | 310001329 | 1.7 | 7 | null | 2016-01-21 | 2016-02-10 | PEMBROLIZUMAB | 02 | N | 310017277 | PEMBROLIZUMAB |
| 310003116 | 310001330 | 0.52 | 64 | Curative (C) | 2015-07-18 | 2015-08-21 | Retinoblastoma JOE | 02 | N | 310017279 | CEV |
| 310003117 | 310001330 | 0.57 | 71 | Curative (C) | 2013-02-08 | 2013-02-17 | Retinoblastoma JOE | N | N | 310017279 | CEV |
| 310003118 | 310001330 | 1.63 | 85.1 | Adjuvant (A) | 2015-07-09 | 2015-07-24 | Carboplatin + Etoposide IV 3 day | N | N | 310017279 | CARBOPLATIN + ETOPOSIDE |
| 310003119 | 310001330 | 1.69 | 5 | Palliative (P) | 2014-01-21 | 2014-01-25 | DOXORUBICIN | N | N | 310017279 | DOXORUBICIN |
| 310003120 | 310001330 | 1.8 | null | Palliative (P) | 2018-08-28 | 2018-09-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017279 | CISPLATIN + GEMCITABINE |
| 310003121 | 310011424 | 1.56 | 62 | Palliative (P) | 2014-02-19 | 2014-02-19 | Carboplatin + Etoposide iv&po | N | N | 310017286 | CARBOPLATIN + ETOPOSIDE |
| 310003122 | 310011424 | 1.6 | 72 | Palliative (P) | 2017-12-15 | 2017-12-23 | DOXORUBICIN | 02 | N | 310017286 | DOXORUBICIN |
| 310003123 | 310001331 | 1.54 | 11.5 | Curative (C) | 2016-10-29 | 2016-11-24 | Cisplatin | 02 | Y | 310017290 | CISPLATIN |
| 310003124 | 310001332 | 1.77 | null | Palliative (P) | 2018-01-25 | 2018-02-02 | Trial Unspecified | 01 | N | 310017292 | TRIAL |
| 310003125 | 310001332 | 1.7 | 10.7 | Curative (C) | null | 2017-05-08 | CHOP R - 21 days | N | null | 310017292 | CHOP R |
| 310003126 | 310001332 | 1.68 | null | Palliative (P) | 2013-07-07 | 2013-07-12 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310017292 | CISPLATIN + GEMCITABINE |
| 310003127 | 310001332 | 1.8 | 110.7 | Curative (C) | null | 2013-11-26 | Cisplatin 7 day | null | Y | 310017292 | CISPLATIN |
| 310003128 | 310001333 | 1.79 | 93.9 | Palliative (P) | 2017-02-25 | 2017-03-07 | DOXORUBICIN | 02 | N | 310017304 | DOXORUBICIN |
| 310003129 | 310001334 | 1.6 | null | Curative (C) | null | 2013-07-18 | CHOP R - 21 days | N | N | 310017308 | CHOP R |
| 310003130 | 310001335 | 1.82 | 119 | Palliative (P) | 2018-04-18 | 2018-04-20 | Ipilimumab | 2 | N | 310017310 | IPILIMUMAB |
| 310003131 | 310006537 | null | 86.6 | Palliative (P) | 2015-01-08 | 2015-01-17 | Ipilimumab | 02 | N | 310017311 | IPILIMUMAB |
| 310003132 | 310008999 | null | 55 | Curative (C) | 2015-01-13 | 2015-01-14 | CHOP R | 2 | N | 310017319 | CHOP R |
| 310003133 | 310008999 | 1.9 | 85.1 | Palliative (P) | null | 2016-01-10 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310017319 | CISPLATIN + GEMCITABINE |
| 310003134 | 310008999 | 1.69 | 56 | Neo-adjuvant (N) | 2014-07-23 | 2014-08-06 | CISPLATIN + GEMCITABINE | N | N | 310017319 | CISPLATIN + GEMCITABINE |
| 310003135 | 310008999 | 0 | 91.9 | Curative (C) | 2013-12-18 | 2014-01-01 | Retinoblastoma JOE | N | N | 310017319 | CEV |
| 310003136 | 310001336 | 1.63 | 56.2 | Disease modification (D) | 2017-05-04 | 2017-05-24 | Trial Unspecified | 01 | N | 310017325 | TRIAL |
| 310003137 | 310001336 | 1.51 | 130.1 | Palliative (P) | 2017-02-02 | 2017-02-10 | PEMBROLIZUMAB | 2 | N | 310017325 | PEMBROLIZUMAB |
| 310003138 | 310001336 | 1.6 | 56.8 | Curative (C) | 2016-09-19 | 2016-09-19 | Cisplatin | 02 | N | 310017325 | CISPLATIN |
| 310003139 | 310001336 | 1.82 | null | Palliative (P) | 2017-07-28 | 2017-08-04 | PEMBROLIZUMAB | 02 | N | 310017325 | PEMBROLIZUMAB |
| 310003140 | 310001337 | 1.78 | 88 | Palliative (P) | 2014-12-04 | 2014-12-04 | CISPLATIN + GEMCITABINE | N | N | 310017331 | CISPLATIN + GEMCITABINE |
| 310003141 | 310001338 | 1.73 | 93.6 | Palliative (P) | 2014-06-19 | 2014-06-19 | Ipilimumab | 02 | N | 310017332 | IPILIMUMAB |
| 310003144 | 310001339 | 1.76 | 60 | Palliative (P) | null | 2017-05-24 | PEMBROLIZUMAB | 02 | N | 310017338 | PEMBROLIZUMAB |
| 310003145 | 310001339 | 1.75 | 124.9 | Neo-adjuvant (N) | 2018-05-18 | 2018-06-16 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310017338 | CISPLATIN + GEMCITABINE |
| 310003146 | 310009002 | 1.93 | 97 | Palliative (P) | 2016-04-02 | 2016-04-12 | CHOP R | 02 | N | 310017341 | CHOP R |
| 310003147 | 310009002 | 1.81 | 61.2 | Palliative (P) | 2018-08-11 | 2018-08-21 | DOXORUBICIN | 02 | N | 310017341 | DOXORUBICIN |
| 310003148 | 310001340 | 1.73 | 67.6 | Adjuvant (A) | 2017-06-01 | 2017-06-04 | Trial Unspecified | 01 | null | 310017348 | TRIAL |
| 310003149 | 310001341 | 1.76 | 71.15 | Palliative (P) | 2018-04-09 | 2018-04-11 | CISPLATIN + GEMCITABINE | 2 | N | 310017350 | CISPLATIN + GEMCITABINE |
| 310003150 | 310006541 | 1.7 | 68.6 | Curative (C) | 2016-08-10 | 2016-08-18 | Cisplatin | null | Y | 310017353 | CISPLATIN |
| 310003151 | 310006541 | 1.61 | 9.2 | Curative (C) | 2016-12-15 | 2016-12-28 | Cisplatin 7 day | N | N | 310017353 | CISPLATIN |
| 310003152 | 310006541 | 1.75 | 71.6 | Adjuvant (A) | 2016-09-17 | 2016-10-11 | Cisplatin 7 day | N | Y | 310017353 | CISPLATIN |
| 310003153 | 310011026 | 1.58 | 61.2 | Palliative (P) | 2017-02-15 | 2017-02-17 | Carboplatin + Etoposide iv&po | 02 | null | 310017357 | CARBOPLATIN + ETOPOSIDE |
| 310003154 | 310011426 | null | 69.3 | Curative (C) | 2014-04-23 | 2014-05-11 | CHOP R | 02 | N | 310017360 | CHOP R |
| 310003155 | 310011655 | 1.62 | 70.7 | Neo-adjuvant (N) | 2018-01-07 | 2018-01-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017361 | CISPLATIN + GEMCITABINE |
| 310003156 | 310001342 | 1.78 | 89.55 | Palliative (P) | 2017-09-04 | 2017-09-14 | PEMBROLIZUMAB | N | N | 310017363 | PEMBROLIZUMAB |
| 310003157 | 310001342 | null | 74.9 | Adjuvant (A) | 2014-06-09 | 2014-06-18 | Carboplatin + Etoposide iv&po | N | N | 310017363 | CARBOPLATIN + ETOPOSIDE |
| 310003158 | 310001342 | null | 60.4 | Palliative (P) | 2014-05-22 | 2014-06-18 | Selumetinib | Y | N | 310017363 | TRIAL |
| 310003159 | 310001342 | 1.74 | 82.3 | Curative (C) | 2017-04-29 | 2017-04-30 | CHOP R - 21 days | N | N | 310017363 | CHOP R |
| 310003160 | 310001343 | 1.67 | 77.4 | Curative (C) | 2014-02-05 | 2014-02-05 | Trial Unspecified | Y | null | 310017369 | TRIAL |
| 310003161 | 310001343 | 1.82 | 72.8 | Palliative (P) | 2014-02-26 | 2014-03-06 | PEMBROLIZUMAB | 02 | N | 310017369 | PEMBROLIZUMAB |
| 310003162 | 310001343 | null | 79.6 | Palliative (P) | 2013-11-22 | 2013-11-22 | Ipilimumab | 2 | N | 310017369 | IPILIMUMAB |
| 310003164 | 310001345 | 1.6 | 57.1 | Palliative (P) | 2016-11-06 | 2016-12-09 | PEMBROLIZUMAB | N | N | 310017376 | PEMBROLIZUMAB |
| 310003165 | 310001346 | 1.68 | 91.099 | Palliative (P) | 2014-09-03 | 2014-09-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017377 | CISPLATIN + GEMCITABINE |
| 310003166 | 310001346 | 1.82 | 97.6 | Palliative (P) | 2018-12-16 | 2019-01-06 | PEMBROLIZUMAB | N | N | 310017377 | PEMBROLIZUMAB |
| 310003167 | 310001346 | 1.75 | null | Palliative (P) | 2016-07-16 | 2016-07-28 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310017377 | CISPLATIN + GEMCITABINE |